• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lyell Immunopharma Inc (NQ: LYEL )

    1.155 +0.005 (+0.43%)
    Streaming Delayed Price Updated: 3:33 PM EDT, Sep 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 331,613
    Open 1.150
    Bid (Size) 1.150 (9)
    Ask (Size) 1.160 (12)
    Prev. Close 1.150
    Today's Range 1.100 - 1.190
    52wk Range 1.090 - 3.256
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Lyell Immunopharma Announces Participation in September Investor Conferences
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
    Via Benzinga

    Performance

    YTD
    -45.26%
    -45.26%
    1 Month
    -15.07%
    -15.07%
    3 Month
    -53.98%
    -53.98%
    6 Month
    -47.02%
    -47.02%
    1 Year
    -42.25%
    -42.25%

    More News

    Read More
    LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q2 2024
    Via InvestorPlace
    Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    3 Biotech Stocks to Sell in August Before They Crash & Burn
    Via InvestorPlace
    Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial
    Via Benzinga
    Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Lyell Immunopharma to Participate in BofA Securities Health Care Conference
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024
    Via InvestorPlace
    Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Lyell Immunopharma Announces Participation in March Investor Conferences
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.